BackIsracann Biosciences Overview

Isracann Biosciences Common Stock

Isracann Biosciences's common stock is $63M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$63.10M
↑ 1.76% YoYΔ $1.09M vs prior year quarter

Peer trimmed avg / median

Loading

Isracann Biosciences Common Stock History

Loading

Isracann Biosciences vs. peers: Common Stock Comparison

Loading

Isracann Biosciences Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Isracann Biosciences (IPOT.CN) FAQ

Isracann Biosciences (IPOT.CN) currently reports a common stock of $63M as of August 2022. That compares with $62M in the prior-year period — up 1.8% year over year. Use the charts on this page to explore Isracann Biosciences's common stock history and peer comparisons.

Isracann Biosciences's common stock increased from $62M to $63M — a 1.8% year-over-year increase (period ending August 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Isracann Biosciences reported $63M in common stock as of August 2022. That compares with $62M in the prior-year period — up 1.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Isracann Biosciences, and consider following IPOT.CN for alerts when major investors trade the stock.